Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Saxenda (liraglutide) and Ozempic (semaglutide) are both medications that belong to the glucagon-like peptide-1 (GLP-1) receptor agonist class and are used to help manage weight and Type 2 diabetes, respectively. While Saxenda is FDA-approved for weight management in adults and children with a high body mass index (BMI), Ozempic is approved for treating Type 2 diabetes and reducing the risk of heart problems in adults with diabetes and heart disease. Saxenda is injected daily, while Ozempic is injected once a week. Both medications can cause side effects like nausea, vomiting, and diarrhea. Saxenda and Ozempic are both available as a prefilled pen for subcutaneous injection. Both medications have warnings about the risk of thyroid cancer and pancreatitis, and neither should be used if you have a personal or family history of certain thyroid cancers. Additionally, Ozempic is sometimes used off-label for weight loss, but it is not FDA-approved for this purpose under the Ozempic brand name.
Saxenda (liraglutide)
Ozempic (semaglutide)
Saxenda (liraglutide)
Ozempic (semaglutide)
Summary of Saxenda vs. Ozempic
Summary for GLP-1 agonist
Prescription only
Saxenda (generic name liraglutide) is a once-daily injection given under the skin that's used for weight loss. It's approved for certain adults and children ages 12 years and up. And it works best when used along with a balanced diet and exercise. This prescription weight loss medication is a glucagon-like peptide-1 (GLP-1) agonist. It works by slowing down your gut and making you feel less hungry. Saxenda (liraglutide) comes as a prefilled pen you use to inject your dose. Some common side effects include nausea, vomiting, and diarrhea.
Summary for GLP-1 agonist
Prescription only
Ozempic (semaglutide) is a GLP-1 agonist used with diet and exercise to help adults manage Type 2 diabetes. It can also lower the risk of heart attack, stroke, and heart-related death in some people with Type 2 diabetes. It comes as a once-weekly injection under the skin and as a tablet taken by mouth once a day. The injection is also approved to help slow worsening kidney problems in people with Type 2 diabetes and chronic kidney disease (CKD). Common side effects include nausea, vomiting, and diarrhea.